Literature DB >> 16631345

A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.

Duangporn Jamsai1, Faten Zaibak, Jim Vadolas, Lucille Voullaire, Kerry J Fowler, Sophie Gazeas, Heidi Peters, Suthat Fucharoen, Robert Williamson, Panayiotis A Ioannou.   

Abstract

Hemoglobin E (HbE) is caused by a G-->A mutation at codon 26 of the beta-globin gene, which substitutes Glu-->Lys. This mutation gives rise to functional but unstable hemoglobin and activates a cryptic splice site causing mild anemia. HbE reaches a carrier frequency of 60-80% in some Southeast Asian populations. HbE causes serious disease when co-inherited with a beta-thalassemia mutation. In this study, we report the creation and evaluation of humanized transgenic mice containing the beta(E) mutation in the context of the human beta-globin locus. Developmental expression of the human beta(E) locus transgene partially complements the hematological abnormalities in heterozygous knockout mice ((mu)beta(th-3/+)) and rescues the embryonic lethality of homozygous knockout mice ((mu)beta(th-3/th-3)). The phenotype of rescued mice was dependent on the transgene copy number. This mouse model displays hematological abnormalities similar to HbE/beta-thalassemia patients and represent an ideal in vivo model system for pathophysiological studies and evaluation of novel therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631345     DOI: 10.1016/j.ygeno.2006.03.009

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Cardiomyocyte ultrastructural damage in β-thalassaemic mice.

Authors:  Chanita Sanyear; Punnee Butthep; Ramaneeya Nithipongvanich; Pornpan Sirankapracha; Pranee Winichagoon; Suthat Fucharoen; Saovaros Svasti
Journal:  Int J Exp Pathol       Date:  2013-10       Impact factor: 1.925

2.  Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8.

Authors:  Supranee Upanan; Andrew T McKie; Gladys O Latunde-Dada; Sittiruk Roytrakul; Chairat Uthaipibull; Peraphan Pothacharoen; Prachya Kongtawelert; Suthat Fucharoen; Somdet Srichairatanakool
Journal:  Int J Hematol       Date:  2017-04-12       Impact factor: 2.490

3.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

4.  Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice.

Authors:  Kanokwan Kulprachakarn; Nittaya Chansiw; Kanjana Pangjit; Chada Phisalaphong; Suthat Fucharoen; Robert C Hider; Sineenart Santitherakul; Somdet Srichairatanakool
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

5.  A Mouse Model for Human Unstable Hemoglobin Santa Ana.

Authors:  Samantha I Miyashiro; Silvia M G Massironi; Claudia M C Mori; Carolina C Cruz; Mitika K Hagiwara; Paulo C Maiorka
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

6.  Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.

Authors:  Kanitta Srinoun; Saovaros Svasti; Worrakavee Chumworathayee; Jim Vadolas; Phantip Vattanaviboon; Suthat Fucharoen; Pranee Winichagoon
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 7.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

8.  Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes.

Authors:  Lynn E Macdonald; Margaret Karow; Sean Stevens; Wojtek Auerbach; William T Poueymirou; Jason Yasenchak; David Frendewey; David M Valenzuela; Cosmas C Giallourakis; Frederick W Alt; George D Yancopoulos; Andrew J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

9.  Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.

Authors:  Lorenzo Capretto; Stefania Mazzitelli; Eleonora Brognara; Ilaria Lampronti; Dario Carugo; Martyn Hill; Xunli Zhang; Roberto Gambari; Claudio Nastruzzi
Journal:  Int J Nanomedicine       Date:  2012-01-18

Review 10.  Recent trends in the gene therapy of β-thalassemia.

Authors:  Alessia Finotti; Laura Breda; Carsten W Lederer; Nicoletta Bianchi; Cristina Zuccato; Marina Kleanthous; Stefano Rivella; Roberto Gambari
Journal:  J Blood Med       Date:  2015-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.